Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (111-120 of 336) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|October 2, 2012
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphomaLiat Vazana-Barad, Galit Granot, Rahav Mor-Tzuntz, et al.
Haematologica|August 8, 2015
The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cellsMartina Rudelius, Hilka Rauert-Wunderlich, Elena Hartmann, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
Electrophoresis|March 25, 2009
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphomaMarc Weinkauf, Yvonne Zimmermann, Elena Hartmann, et al.
Hemasphere|April 21, 2021
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 PandemicMartin Dreyling, Igor Aurer, Massimo Federico, et al.
Hemasphere|November 2, 2020
Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)Igor Aurer, Martin Dreyling, Massimo Federico, et al.
Drugs|September 22, 2019
Are Biosimilars the Future of Oncology and Haematology?Pier Luigi Zinzani, Martin Dreyling, William Gradishar, et al.
Journal of the National Cancer Institute|February 13, 2009
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trialsLiat Vidal, Anat Gafter-Gvili, Leonard Leibovici, et al.
Cell Cycle (Georgetown, Tex.)|October 14, 2009
3'UTR mediated regulation of the cyclin D1 proto-oncogeneAnagha Deshpande, Alessandro Pastore, Aniruddha J Deshpande, et al.
Histopathology|March 25, 2009
The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stageKlaus Willenbrock, Christoph Renné, Marietta Rottenkolber, et al.
Pageof 34

Showing results (111-120 of 336) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|October 2, 2012
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphomaLiat Vazana-Barad, Galit Granot, Rahav Mor-Tzuntz, et al.
Haematologica|August 8, 2015
The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cellsMartina Rudelius, Hilka Rauert-Wunderlich, Elena Hartmann, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
Electrophoresis|March 25, 2009
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphomaMarc Weinkauf, Yvonne Zimmermann, Elena Hartmann, et al.
Hemasphere|April 21, 2021
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 PandemicMartin Dreyling, Igor Aurer, Massimo Federico, et al.
Hemasphere|November 2, 2020
Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)Igor Aurer, Martin Dreyling, Massimo Federico, et al.
Drugs|September 22, 2019
Are Biosimilars the Future of Oncology and Haematology?Pier Luigi Zinzani, Martin Dreyling, William Gradishar, et al.
Journal of the National Cancer Institute|February 13, 2009
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trialsLiat Vidal, Anat Gafter-Gvili, Leonard Leibovici, et al.
Cell Cycle (Georgetown, Tex.)|October 14, 2009
3'UTR mediated regulation of the cyclin D1 proto-oncogeneAnagha Deshpande, Alessandro Pastore, Aniruddha J Deshpande, et al.
Histopathology|March 25, 2009
The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stageKlaus Willenbrock, Christoph Renné, Marietta Rottenkolber, et al.
Pageof 34